Healthcare - Biotechnology - NASDAQ - US
$ 0.1019
-70 %
$ 29.4 M
Market Cap
-0.15
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
1199.91%
EBIT
Estimate
6.84%
Net Income
Estimate
24.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Eyenovia, Inc.
EYEN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart EYEN
EBIT FORECAST
EBIT Forecast Chart EYEN
NET INCOME FORECAST
Net Income Chart EYEN